HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miriam Wittmann Selected Research

Miriam Wittmann Research Topics

Disease

21Inflammation (Inflammations)
01/2021 - 12/2003
18Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 12/2003
14Skin Diseases (Skin Disease)
11/2021 - 06/2005
11Eczema
02/2022 - 06/2005
7Psoriatic Arthritis
01/2022 - 06/2013
7Necrosis
01/2020 - 12/2003
5Rheumatoid Arthritis
10/2022 - 01/2018
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022 - 06/2015
4Autoimmune Diseases (Autoimmune Disease)
10/2022 - 07/2006
4Cutaneous Lupus Erythematosus
06/2013 - 10/2008
3Spondylarthropathies
10/2022 - 01/2019
3Arthritis (Polyarthritis)
10/2022 - 01/2021
2Enthesopathy
10/2022 - 01/2019
2Atopic Dermatitis (Atopic Eczema)
01/2021 - 02/2013
2Neoplasms (Cancer)
12/2015 - 03/2010
1Drug-Related Side Effects and Adverse Reactions
10/2022
1Anterior Uveitis
11/2021
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
11/2021
1Food Hypersensitivity (Food Allergy)
11/2021
1Asthma (Bronchial Asthma)
11/2021
1Joint Diseases (Joint Disease)
01/2021
1Osteoarthritis
11/2019
1Rosacea (Acne Rosacea)
01/2019
1Connective Tissue Diseases (Connective Tissue Disease)
10/2018
1Fever (Fevers)
01/2018
1Persistent Infection
08/2015
1Disease Progression
04/2015
1Pruritus (Itching)
08/2014
1Chronic Obstructive Pulmonary Disease (COPD)
06/2013
1Mitochondrial Diseases (Mitochondrial Disease)
08/2012
1Type 2 Diabetes Mellitus (MODY)
08/2012
1Superinfection
06/2012
1Melanoma (Melanoma, Malignant)
12/2011
1Cryopyrin-Associated Periodic Syndromes
03/2010
1Gout
03/2010

Drug/Important Bio-Agent (IBA)

16CytokinesIBA
10/2022 - 12/2003
7Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2006
6Interleukin-12 (IL 12)IBA
06/2019 - 10/2004
5Interleukin-13IBA
10/2022 - 05/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 12/2003
5Interleukin-18 (Interleukin 18)IBA
01/2012 - 12/2003
4InterferonsIBA
12/2020 - 06/2005
4InterleukinsIBA
01/2020 - 06/2005
4Interleukin-27 (Interleukin 27)IBA
06/2019 - 07/2009
3dupilumabIBA
10/2022 - 01/2021
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2015
3Interleukin-17 (Interleukin 17)IBA
11/2021 - 12/2010
3Interleukin-23 (Interleukin 23)IBA
01/2021 - 06/2015
3InflammasomesIBA
08/2012 - 03/2010
2Biological ProductsIBA
10/2022 - 01/2016
2Interleukin-1 (Interleukin 1)IBA
01/2021 - 01/2018
2Interferon Type IIBA
12/2020 - 01/2020
2apremilastIBA
01/2020 - 06/2013
2Ustekinumab (CNTO 1275)FDA Link
01/2019 - 06/2015
2LipopolysaccharidesIBA
01/2018 - 12/2003
2Type I Tumor Necrosis Factor ReceptorsIBA
01/2018 - 08/2012
2Histamine (Histamine Dihydrochloride)FDA Link
12/2008 - 05/2005
2Interferon-gamma (Interferon, gamma)IBA
12/2008 - 12/2003
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
10/2022
1AlitretinoinFDA Link
02/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
12/2020
1Anti-Citrullinated Protein AntibodiesIBA
10/2020
1amsonic acid (DAS)IBA
01/2020
1Bone Marrow Stromal Antigen 2IBA
01/2020
1Interleukin-23 Subunit p19IBA
06/2019
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
10/2018
1Antinuclear AntibodiesIBA
10/2018
1Janus KinasesIBA
01/2018
1tofacitinibIBA
01/2018
1Janus Kinase InhibitorsIBA
01/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2018
1protease SIBA
01/2017
1cathepsin SIBA
01/2017
1EnzymesIBA
01/2016
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2015
1CollagenIBA
12/2015
1Oncogene Proteins (Oncogene Protein)IBA
08/2015
1Imiquimod (Aldara)FDA LinkGeneric
08/2015
1Rituximab (Mabthera)FDA Link
06/2015
1Pharmaceutical PreparationsIBA
04/2015
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
06/2013
1Phosphodiesterase 4 InhibitorsIBA
06/2013
1Monoclonal AntibodiesIBA
06/2013
1Tumor Necrosis Factor InhibitorsIBA
06/2013
1RoflumilastIBA
06/2013
1Methotrexate (Mexate)FDA LinkGeneric
06/2013
1Interleukin-33IBA
02/2013
1AutoantibodiesIBA
08/2012
1Cytokine Receptors (Cytokine Receptor)IBA
08/2012
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2012
1AntigensIBA
08/2012
1Suppressor of Cytokine Signaling ProteinsIBA
03/2012
1ChemokinesIBA
12/2010

Therapy/Procedure

8Therapeutics
01/2022 - 07/2006
1Surgical Tape
01/2019
1Topical Administration
01/2019
1Retreatment
01/2018